Health facilities in the Gaza Strip face a serious shortage of drugs and medical supplies. In late September, 36 percent of essential drugs were lacking. While MSF makes regular donations, no aid actor can meet the full range of needs.
The Israeli embargo of the Gaza Strip, which began in 2007, together with years of financial crisis within the Palestinian Authority in Ramallah and the chronic lack of cooperation between the Palestinian Authority and Gaza authorities, have caused harm and threaten Gaza's health system and its patients.
Drug companies stop supply
Health facilities in the Gaza Strip face a serious shortage of drugs and medical supplies. While MSF makes regular donations, no aid actor can meet the full range of needs. © Juan Carlos Tomasi
Last spring, drug companies stopped supplying the Palestinian Authority.
The situation, which had been worsening steadily for several years, deteriorated further in 2011 and has reached an alarming level.
As Israeli bombs struck the Gaza Strip in mid-August, local health authorities called on international aid actors working in the area for help.
Since that time, they have asked for donations on a regular, long-term basis.
However, no humanitarian actor – including MSF – has the financial and/or logistical resources to provide the drugs and medical supplies needed by the Territory's health facilities.
Thirty six percent of essential medicines are lacking. Stock-outs represent a real threat to patient health.
In late September 2011, 164 essential drugs – 36 percent of necessary supplies, compared to 25 percent in 2010 – were completely unavailable. Only 260 of the 900 required medical supply items (specifically, single-use items) were supplied.
For now, UNRWA clinics, run by the UN relief agency for Palestinian refugees, provide patients with chronic illnesses access to treatment.
The medical areas most affected are:
Intensive care (certain anesthetics are lacking altogether)
Treatments to prevent organ transplant rejection
Hematology (no coagulants)
Psychiatric medications (only 33 of the 46 essential psychiatric drugs are available)
Ophthalmology (all eye surgeries have been halted)
Catheterisation laboratory procedures for the diagnosis and treatment of heart disease
Patients' lives in danger
The five medical centers that treat kidney disease in Gaza will face drug shortages within a few weeks and their patients' lives will then be in grave danger.
Throughout 2011 MSF made periodic donations when specific, urgent needs arose.
Since 2008, the organisation has regularly criticised the politicisation of the Palestinian health sector and the impacts of the conflicts – both internal and external – on patients deprived of critical medications and medical care.
While MSF, an emergency medical aid organisation, can establish an action and donation plan, it cannot provide the full range of drugs and medical supplies. We remain particularly concerned about the future of Gaza's patients and ill residents.